137 related articles for article (PubMed ID: 37511173)
1. Synthesis and Anti-Proliferative Activity of 5-Benzoyl and 5-Benzylhydroxy Derivatives of 3-Amino-2-Arylcarboxamido-Thieno[2-3-
Morphet B; Rees SWP; Haverkate NA; Aziz H; Leung E; Pilkington LI; Barker D
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511173
[TBL] [Abstract][Full Text] [Related]
2. Disruption of Crystal Packing in Thieno[2,3-
Haverkate NA; Leung E; Pilkington LI; Barker D
Molecules; 2022 Jan; 27(3):. PubMed ID: 35164101
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and cytotoxicity of thieno[2,3-b]quinoline-2-carboxamide and cycloalkyl[b]thieno[3,2-e]pyridine-2-carboxamide derivatives.
Leung E; Pilkington LI; van Rensburg M; Jeon CY; Song M; Arabshahi HJ; De Zoysa GH; Sarojini V; Denny WA; Reynisson J; Barker D
Bioorg Med Chem; 2016 Mar; 24(5):1142-54. PubMed ID: 26853836
[TBL] [Abstract][Full Text] [Related]
4. New C2- and N3-Modified Thieno[2,3-d]Pyrimidine Conjugates with Cytotoxicity in the Nanomolar Range.
Mavrova AT; Dimov S; Yancheva D; Rangelov M; Wesselinova D; Naydenova E
Anticancer Agents Med Chem; 2022; 22(6):1201-1212. PubMed ID: 34315388
[TBL] [Abstract][Full Text] [Related]
5. Improving the solubility of anti-proliferative thieno[2,3-b]quinoline-2-carboxamides.
Haverkate NA; van Rensburg M; Kumara S; Reynisson J; Leung E; Pilkington LI; Barker D
Bioorg Med Chem; 2021 May; 37():116092. PubMed ID: 33725562
[TBL] [Abstract][Full Text] [Related]
6. Tethered Aryl Groups Increase the Activity of Anti-Proliferative Thieno[2,3-
Haverkate NA; Leung E; Pilkington LI; Barker D
Pharmaceutics; 2021 Nov; 13(12):. PubMed ID: 34959302
[TBL] [Abstract][Full Text] [Related]
7. Thieno[2,3-d]pyrimidin-4(3H)-one Derivatives of Benzimidazole as Potential Anti- Breast Cancer (MDA-MB-231, MCF-7) Agents.
Dimov S; Mavrova AT; Yancheva D; Nikolova B; Tsoneva I
Anticancer Agents Med Chem; 2021; 21(11):1441-1450. PubMed ID: 32698751
[TBL] [Abstract][Full Text] [Related]
8. Identification of anticancer agents based on the thieno[2,3-b]pyridine and 1H-pyrazole molecular scaffolds.
Eurtivong C; Reynisdóttir I; Kuczma S; Furkert DP; Brimble MA; Reynisson J
Bioorg Med Chem; 2016 Aug; 24(16):3521-6. PubMed ID: 27288184
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and cytotoxicity of thieno[2,3-b]pyridine and furo[2,3-b]pyridine derivatives.
Hung JM; Arabshahi HJ; Leung E; Reynisson J; Barker D
Eur J Med Chem; 2014 Oct; 86():420-37. PubMed ID: 25194934
[TBL] [Abstract][Full Text] [Related]
10. 3-Amino-thieno[2,3-b]pyridines as microtubule-destabilising agents: Molecular modelling and biological evaluation in the sea urchin embryo and human cancer cells.
Eurtivong C; Semenov V; Semenova M; Konyushkin L; Atamanenko O; Reynisson J; Kiselyov A
Bioorg Med Chem; 2017 Jan; 25(2):658-664. PubMed ID: 27956038
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of new thieno[2,3-b]pyridine derivatives as pim-1 inhibitors.
Naguib BH; El-Nassan HB
J Enzyme Inhib Med Chem; 2016 Dec; 31(6):1718-25. PubMed ID: 27541740
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and biological evaluation of thieno[3,2-d]pyrimidine derivatives containing aroyl hydrazone or aryl hydrazide moieties for PI3K and mTOR dual inhibition.
Han Y; Tian Y; Wang R; Fu S; Jiang J; Dong J; Qin M; Hou Y; Zhao Y
Bioorg Chem; 2020 Nov; 104():104197. PubMed ID: 32927132
[TBL] [Abstract][Full Text] [Related]
13. New Approaches for the Uses of Cyclohexan-1,4-dione for the Synthesis of 5,6,7,8-tetrahydrobenzo[4,5]thieno[2,3-b]pyridine Derivatives used as Potential Anti-prostate Cancer Agents and Pim-1 Kinase Inhibitors.
Mohareb RM; Abdo NYM; El-Sharkawy KA
Anticancer Agents Med Chem; 2018; 18(12):1736-1749. PubMed ID: 29866019
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of Novel Pyridine Bearing Biologically Active Imidiazolyl, Pyrazolyl, Oxa/thiadiazolyl and Urea Derivatives as Promising Anticancer Agents.
Hafez HN; El-Gazzar ABA
Curr Org Synth; 2020; 17(1):55-64. PubMed ID: 32103718
[TBL] [Abstract][Full Text] [Related]
15. Evidence that phospholipase C is involved in the antitumour action of NSC768313, a new thieno[2,3-b]pyridine derivative.
Reynisson J; Jaiswal JK; Barker D; D'mello SA; Denny WA; Baguley BC; Leung EY
Cancer Cell Int; 2016; 16():18. PubMed ID: 26966420
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and biological evaluation of novel thieno[3,2-d]pyrimidine derivatives containing diaryl urea moiety as potent antitumor agents.
Liu Z; Wang Y; Lin H; Zuo D; Wang L; Zhao Y; Gong P
Eur J Med Chem; 2014 Oct; 85():215-27. PubMed ID: 25086238
[TBL] [Abstract][Full Text] [Related]
17. New thieno[3,2-d]pyrimidine-based derivatives: Design, synthesis and biological evaluation as antiproliferative agents, EGFR and ARO inhibitors inducing apoptosis in breast cancer cells.
Farghaly AM; AboulWafa OM; Baghdadi HH; Abd El Razik HA; Sedra SMY; Shamaa MM
Bioorg Chem; 2021 Oct; 115():105208. PubMed ID: 34365057
[TBL] [Abstract][Full Text] [Related]
18. Investigation into Improving the Aqueous Solubility of the Thieno[2,3-b]pyridine Anti-Proliferative Agents.
Zafar A; Pilkington LI; Haverkate NA; van Rensburg M; Leung E; Kumara S; Denny WA; Barker D; Alsuraifi A; Hoskins C; Reynisson J
Molecules; 2018 Jan; 23(1):. PubMed ID: 29324695
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and Evaluation of 2-Naphthaleno trans-Stilbenes and Cyanostilbenes as Anticancer Agents.
Madadi NR; Penthala NR; Ketkar A; Eoff RL; Trujullo-Alonso V; Guzman ML; Crooks PA
Anticancer Agents Med Chem; 2018; 18(4):556-564. PubMed ID: 28403783
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, anticancer activity and effects on cell cycle profile and apoptosis of novel thieno[2,3-d]pyrimidine and thieno[3,2-e] triazolo[4,3-c]pyrimidine derivatives.
Kandeel MM; Refaat HM; Kassab AE; Shahin IG; Abdelghany TM
Eur J Med Chem; 2015 Jan; 90():620-32. PubMed ID: 25499930
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
